MedDevices AI
By
Is Johnson & Johnson Preparing to Divest DePuy Synthes in a $20 Billion Strategic Pivot Toward Pharmaceuticals?
Will Johnson & Johnson’s Orthopedics Review Reshape the Global MedTech Landscape? Johnson & Johnson is reportedly exploring a…
Will Johnson & Johnson’s 2025 Earnings Reinforce Confidence in Its Pharma-Led Growth Engine?
Late January 2026 | Full-Year 2025 Earnings Preview | Diversified Pharma Outlook Johnson & Johnson (J&J) is set…
Can Johnson & Johnson’s Verb Surgical and Ottava Platforms Turn the Operating Room into an Intelligent, Connected System?
Executive Summary Johnson & Johnson’s surgical technology efforts—anchored in the Verb Surgical initiative and now evolving under the…
Can Medtronic’s AI-Enabled Devices Transform Outcomes Across Cardiac, Diabetes, and Neuro Care Pathways?
Executive Summary Medtronic, a global leader in medical technology, is accelerating the integration of artificial intelligence and advanced…
Can J&J’s Newly FDA-Approved Dual-Energy Ablation Catheter Help It Reclaim Ground Lost to Boston Scientific and Medtronic in PFA?
Key Highlights A Strategic Answer to Lost PFA Ground Johnson & Johnson enters the U.S. dual-energy ablation market…
Tsinghua’s Agent Hospital Pilots: World’s First AI Hospital or Closed Data Experiment?
Tsinghua University’s “world’s first AI Hospital” advanced public pilots February 28-March 2, 2026—deploying 42 AI agents across 300+…
